Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 1/2005

01-03-2005 | Original Article

Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach

Results of a controlled clinical trial

Authors: Agustin Avilés, MD, María Jesús Nambo, Natividad Neri, Alejandra Talavera, Sergio Cleto

Published in: Medical Oncology | Issue 1/2005

Login to get access
Metadata
Title
Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach
Results of a controlled clinical trial
Authors
Agustin Avilés, MD
María Jesús Nambo
Natividad Neri
Alejandra Talavera
Sergio Cleto
Publication date
01-03-2005
Publisher
Humana Press
Published in
Medical Oncology / Issue 1/2005
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1385/MO:22:1:057

Other articles of this Issue 1/2005

Medical Oncology 1/2005 Go to the issue

Original Article

Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma

Review

A clinical and biological overview of gastrointestinal stromal tumors

Original Article

A descriptive study of second primary malignancies associated to breast cancer in a Mexican Hispanic population

Original Article

Bone marrow hyaluronan distribution in patients with acute myeloid leukemia

BookReview

Book review

Original Article

The role of cystatin C and the angiogenic cytokines VEGF and bFGF in patients with esophageal carcinoma
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits